Found: 19
Select item for more details and to access through your institution.
Alemtuzumab: Rare serious adverse events of a high-efficacy drug.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 737, doi. 10.1177/1352458520913277
- By:
- Publication type:
- Article
Samuel Ludwin: Obituary.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 622, doi. 10.1177/1352458520915815
- By:
- Publication type:
- Article
Family planning is the second most relevant factor for treatment decisions after disease activity – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 644, doi. 10.1177/1352458520907902
- By:
- Publication type:
- Article
A novel classification of fatigue in multiple sclerosis based on longitudinal assessments.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 725, doi. 10.1177/1352458519898112
- By:
- Publication type:
- Article
Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 659, doi. 10.1177/1352458519840757
- By:
- Publication type:
- Article
Family planning is the second most relevant factor for treatment decisions after disease activity – No.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 642, doi. 10.1177/1352458520902343
- By:
- Publication type:
- Article
Toward biologically meaningful categories of MS-related fatigue.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Family planning is the second most relevant factor for treatment decisions after disease activity – Yes.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 640, doi. 10.1177/1352458519877689
- By:
- Publication type:
- Article
Optical coherence tomography and multiple sclerosis: Update on clinical application and role in clinical trials.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 624, doi. 10.1177/1352458519872751
- By:
- Publication type:
- Article
Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 735, doi. 10.1177/1352458519855725
- By:
- Publication type:
- Article
Response to Hyun J.W. et al. "Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11 C-PBR28 MR-PET.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 668, doi. 10.1177/1352458519843048
- By:
- Publication type:
- Article
Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 679, doi. 10.1177/1352458519841810
- By:
- Publication type:
- Article
Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 706, doi. 10.1177/1352458519838205
- By:
- Publication type:
- Article
Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 696, doi. 10.1177/1352458519837706
- By:
- Publication type:
- Article
Two-year dynamic functional network connectivity in clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 645, doi. 10.1177/1352458519837704
- By:
- Publication type:
- Article
Autonomic dysfunction in people with neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 688, doi. 10.1177/1352458519837703
- By:
- Publication type:
- Article
Letter to the editor regarding "Therapeutic drug monitoring of natalizumab".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Robot-assisted gait training is not superior to intensive overground walking in multiple sclerosis with severe disability (the RAGTIME study): A randomized controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 716, doi. 10.1177/1352458519833901
- By:
- Publication type:
- Article